Espoir (Im)patient invites French healthcare professionals to learn about prescribing cannabis for therapeutic purposes
The conversation surrounding medical cannabis and its legal regulation continues.
A few weeks ago, the« joint information mission on the regulation and impact of different uses of cannabis »was launched at the French National Assembly. At the same time, the CST tasked by the ANSM with studying the operational parameters of the issue is making progress, with plans for the start of French experimentation in September 2020.
While we await the transition of conversations towards regulatory change, one question remains: are healthcare professionals sufficiently aware of the use of cannabis for therapeutic purposes in patients? While some are already familiar with the subject, others know little or nothing about it. This may be due to the stigma attached to the use of these products, or simply to a lack of information about this plant that has hitherto been banned from mainstream medical circles.
To this end, ANSM is planning a compulsory 3.5-hour e-learning course for future doctors and pharmacists taking part in the trial. The program will be developed by teachers, clinicians and patient experts. Validation of the proposed modules will enable them to prescribe and dispense cannabis-based medicines to patients, as well as being included in the follow-up register. This program is the fruit of a compromise to provide training that will be both sufficiently well attended, especially by GPs, and sufficiently comprehensive to give prescribers confidence in their ability to move forward on this subject with their patients.
But the fact remains. At this stage of the conversation, only a very small number of people have been initiated. Visit Espoir (Im)patient platform invites healthcare professionals to join them for a second Round Table on February 15, 2020 at the 11th arrondissement town hall, starting at 9:00 am. This meeting will be an opportunity for patients to make their voices heard and share their personal experiences.
This participatory process supports the government's new approach of considering cannabis as a medicine in its own right, with its own particularities comparable to products undergoing a conventional MA process.
To register, simply to fill in this questionnaire.
Date Saturday, February 15, 2020
Location Salle des Fêtes de la Mairie du 11ème arrondissement, 12 Place Léon Blum, Paris.
Opening hours 9am-1pm
-
Cannabis in France4 weeks ago
France Sets July as the Deadline for the Widespread Adoption of Medical Cannabis
-
Cannabis in Europe3 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France3 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in Ireland4 weeks ago
The Irish Parliament recommends decriminalizing all drugs
-
Cannabis in the U.S.3 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Cannabis in Switzerland4 weeks ago
St. Gallen, Switzerland, Launches Its 8th Legal Cannabis Pilot Project
-
Cannabis in France4 weeks ago
Reunion Island: The CBD Cannabis Cup Returns to Jardin Maniron on August 16, 2026
-
Business2 weeks ago
China Invests $10 Million in Medical Cannabis in Lebanon


You must be logged in to post a comment Login